Stock AnalizDoximity, Inc. DOCS
EDP Services · IPO 2021 · data as of November 13, 2026
Doximity, Inc. (DOCS) is a technology company listed in the US with a market value of about $5.9B. In the twelve months to September 30, 2026 it had revenue of $662M and net income of $140M, a net margin of 21.1%.
Its overall Stock Analiz score is 3.2 out of 5 (average). The strongest part is track record (5/5); the weakest is value (1/5).
Key numbers: a P/E of 46.3, a price to free cash flow of 20.0, 5-year revenue growth of 26% a year, a 5-year average ROIC of 14%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 31% below the current price.
Score: 3.2 / 5
Checks passed
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- Profit margin improving
- Pays a dividend
- 20% to 100% of free cash flow returned to shareholders
- Dividend 3 years in a row
Valuation
Growth and quality
Financials, last 7 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $662M | $645M | $570M | $475M | $419M | $344M | $207M | $116M |
| Net income | $140M | $196M | $223M | $148M | $113M | $155M | $50M | $30M |
| Free cash flow | $297M | $326M | $273M | $184M | $178M | $125M | $83M | $26M |
| EPS (diluted) | $0.72 | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | $0.23 | $0.13 |
| Net margin | 21.1% | 30.4% | 39.1% | 31.0% | 26.9% | 45.1% | 24.3% | 25.6% |
| ROIC | — | 17.5% | 17.6% | 14.3% | 10.8% | 10.2% | 68.1% | 1541.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 18 analysts is $31.22, 6% below the current price; targets range from $18.00 to $41.00; the consensus rating is “Hold”; expected EPS is $1.35 for the fiscal year ending March 31, 2027.
Frequently asked questions
What is Doximity’s P/E ratio?
About 46.3, based on the last twelve months of diluted earnings per share (forward P/E about 22.6).
Is Doximity stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 31% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Doximity pay a dividend?
Not currently.
Is Doximity a good stock to buy?
We do not give buy or sell advice. Doximity scores 3.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.